PRTA

PROTHENA CORP PLC

PRTA·G72800108·US·Common Stock·Healthcare - Biotechnology-Activist

PRTA (PROTHENA CORP PLC) is held by 99 institutional investors as of Q1 2026. Largest holders: FMR LLC ($73.4M), BlackRock, Inc. ($45.1M), STATE STREET CORP ($18.8M). Net institutional sentiment: Mixed.

99
Holders
Avg rating(24 Elite)
$329.6M
Total Value
57% (107)
Fund Consensus
55 buying - 41 selling
PRTASmart Money Verdict
View all
Held by 99 funds
24 elite
Who's Trading
InsiderSPSCULLY WILLIAM PBuy $158KJun 16, 2026
InsiderSPSCULLY WILLIAM PBuy $465KJun 4, 2026
InsiderSPSCULLY WILLIAM PBuy $981KMay 22, 2026
ActivistRURubric Capital Management LP9.3%May 15, 2026
ActivistSWSCULLY WILLIAM P10.3%May 11, 2026
ActivistADADAR1 Capital Management, LLC2.7%Nov 14, 2025
ActivistFTFennell Todd W.8.4%Nov 12, 2025
ActivistBlackRock, Inc.BlackRock, Inc.5.7%Oct 17, 2025
ActivistT. Rowe Price Associates, Inc.T. Rowe Price Associates, Inc.0.1%Aug 14, 2025
InsiderSPSCULLY WILLIAM PBuy $1.3MJan 14, 2025
13F: Insider & Congress:
Fund
Action
Shares
Value
Weight
Est. P&L
Conviction
Unchanged
7.6M$73.4M0.0%-37.90%
0
Increased
4.6M(+13.1%)$45.1M0.0%-32.22%
33
Decreased
1.9M(-14.5%)$18.8M0.0%-49.63%
0
Increased
1.8M(+4.9%)$17.1M0.0%+3.79%
30
New
1.4M$14.1M0.0%-1.28%
39
Decreased
1.2M(-1.3%)$12M0.0%-35.33%
0
Increased
1.2M(+80.0%)$11.7M0.0%+2.50%
43
Increased
1.1M(+3.3%)$10.7M0.0%-65.59%
29
Increased
1.1M(+8.8%)$10.3M0.0%-13.82%
30
Decreased
972,017(-0.6%)$9.4M0.0%+27.64%
0
Decreased
818,885(-12.4%)$8M0.0%-18.24%
0
Increased
782,603(+0.9%)$7.6M0.0%-78.36%
28
Increased
759,368(+0.0%)$7.4M0.0%-9.85%
27
Increased
614,603(+50.8%)$6M0.0%+15.63%
38
Increased
607,515(+39.5%)$5.9M0.0%-20.96%
36
Decreased
563,082(-2.6%)$5.5M0.0%-62.37%
0
New
484,126$4.7M0.0%-1.28%
37
Decreased
435,574(-52.3%)$4.2M0.0%+20.82%
0
Increased
424,596(+0.1%)$4.1M0.0%-4.03%
27
Decreased
399,830(-53.5%)$3.9M0.0%-4.23%
0

Showing 1-20 of 107

1 / 6

Other Healthcare stocks held by institutions

Data sourced from four SEC data sources: 13F, Form 4, 13D/13G, and STOCK Act. Not financial advice. Full disclaimer

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used